{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:39:12Z","timestamp":1792172352468,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T00:00:00Z","timestamp":1455840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jare.2016.02.004","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T16:58:28Z","timestamp":1456333108000},"page":"348-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies"],"prefix":"10.1016","volume":"7","author":[{"given":"Samar K.M.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel M.","family":"El Behairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Warda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3A","key":"10.1016\/j.jare.2016.02.004_b0005","first-page":"S421","article-title":"Anaemia as a risk factor for chronic kidney disease","volume":"5","author":"H\u00f6rl","year":"2009","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jare.2016.02.004_b0010","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","article-title":"Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988\u20131994)","volume":"162","author":"Astor","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jare.2016.02.004_b0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"13 suppl 8","key":"10.1016\/j.jare.2016.02.004_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2146\/ajhp070181","article-title":"Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview","volume":"64","author":"Dowling","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jare.2016.02.004_b0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2362.2009.02182.x","article-title":"Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy","volume":"39","author":"Weiss","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jare.2016.02.004_b0030","unstructured":"KDOQI. Clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease (2007): update of hemoglobin target. Am J Kidney Dis 2007; (September suppl)."},{"key":"10.1016\/j.jare.2016.02.004_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1542-4758.2008.00233.x","article-title":"Health-related quality of life in the era of erythropoietin","volume":"12","author":"Weisbord","year":"2008","journal-title":"Hemodial Int"},{"issue":"suppl 2","key":"10.1016\/j.jare.2016.02.004_b0040","first-page":"ii1","article-title":"European best practice guidelines working group (2004). Revised European best practice guidelines for the management of anemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Trans"},{"key":"10.1016\/j.jare.2016.02.004_b0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/TCRM.S4856","article-title":"Associations of anemia persistency with medical expenditures in medicare ESRD patients on dialysis","volume":"5","author":"Liu","year":"2009","journal-title":"Ther Clin Risk Manage"},{"issue":"suppl 8","key":"10.1016\/j.jare.2016.02.004_b0050","doi-asserted-by":"crossref","first-page":"viii2","DOI":"10.1093\/ndt\/gfh1109","article-title":"Inflammation and resistance to erythropoiesis stimulating agents \u2013 what do we know and what needs to be clarified?","volume":"20","author":"Smrzova","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.jare.2016.02.004_b0055","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes","volume":"363","author":"Solomon","year":"2010","journal-title":"New Engl J Med"},{"issue":"8","key":"10.1016\/j.jare.2016.02.004_b0060","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/ndt\/gfq802","article-title":"RISCAVID study group. Anaemia and resistance to erythropoiesis stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study","volume":"26","author":"Panichi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2016.02.004_b0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2369-10-8","article-title":"Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients\u2014an observational study","volume":"10","author":"Fassett","year":"2009","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.jare.2016.02.004_b0070","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpneph0847","article-title":"Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?","volume":"4","author":"Vaziri","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1542-4758.2011.00635.x","article-title":"IL-6 is an independent risk factor for resistance to erythropoiesis-stimulating agents in hemodialysis patients without iron deficiency","volume":"16","author":"Won","year":"2012","journal-title":"Hemodial Int"},{"issue":"suppl 1","key":"10.1016\/j.jare.2016.02.004_b0080","doi-asserted-by":"crossref","first-page":"i18","DOI":"10.1093\/ndtplus\/sfn176","article-title":"Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness","volume":"2","author":"de Francisco","year":"2009","journal-title":"NDT Plus"},{"key":"10.1016\/j.jare.2016.02.004_b0085","first-page":"1154","article-title":"Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in dialytic patients","volume":"19","author":"Panichi","year":"2004","journal-title":"NDT"},{"key":"10.1016\/j.jare.2016.02.004_b0090","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1159\/000142147","article-title":"Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients","volume":"28","author":"Costa","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2567.2001.01334.x","article-title":"Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine","volume":"104","author":"Viora","year":"2001","journal-title":"Immunology"},{"issue":"1\u20132","key":"10.1016\/j.jare.2016.02.004_b0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0009-8981(02)00211-5","article-title":"An evaluation of level of oxidative stress and protein glycation in non-diabetic undialyzed chronic renal failure patients","volume":"324","author":"Selvaraj","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jare.2016.02.004_b0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12011-010-8776-0","article-title":"The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study","volume":"142","author":"Zachara","year":"2011","journal-title":"Biol Trace Elem Res"},{"issue":"3","key":"10.1016\/j.jare.2016.02.004_b0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1525-139X.2001.00052.x","article-title":"Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy","volume":"14","author":"Descamps-Latscha","year":"2001","journal-title":"Semin Dial"},{"key":"10.1016\/j.jare.2016.02.004_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000070991","article-title":"Vitamin C in chronic kidney disease and hemodialysis patients","volume":"26","author":"Deicher","year":"2003","journal-title":"Kidney Blood Press Res"},{"issue":"suppl 2","key":"10.1016\/j.jare.2016.02.004_b0120","first-page":"ii6","article-title":"European best practice guidelines for anemia, section III. Treatment of renal anemia","volume":"19","author":"Cameron","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2016.02.004_b0125","doi-asserted-by":"crossref","first-page":"185D","DOI":"10.1016\/0165-022X(86)90092-8","article-title":"Application of thiobarbituric acid assay to the measurement of lipid peroxidation products in microsomes","volume":"13","author":"Albro","year":"1986","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.jare.2016.02.004_b0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of superoxide anion radical in antioxidation of pyrogallol and a constituent assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur J Biochem"},{"issue":"22","key":"10.1016\/j.jare.2016.02.004_b0135","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1093\/nar\/25.22.4692","article-title":"Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques","volume":"25","author":"Aljanabi","year":"1997","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.jare.2016.02.004_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method","volume":"90","author":"Satoh","year":"1978","journal-title":"Clin Chem Acta"},{"issue":"5259","key":"10.1016\/j.jare.2016.02.004_b0145","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jare.2016.02.004_b0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0009-8981(78)90128-6","article-title":"A simple colorimetric method for ascorbic acid determination in blood plasma","volume":"86","author":"Kyaw","year":"1978","journal-title":"Clin Chem Acta"},{"key":"10.1016\/j.jare.2016.02.004_b0155","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia \u2013 the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jare.2016.02.004_b0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0272-6386(03)00353-6","article-title":"Associations between circulating inflammatory markers and residual renal function in CRF patients","volume":"41","author":"Pecoits-Filho","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jare.2016.02.004_b0165","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/01.ASN.0000016440.52271.F7","article-title":"Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness","volume":"13","author":"Eschbach","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.jrn.2004.09.024","article-title":"Inflammation and resistance to treatment with recombinant human erythropoietin","volume":"15","author":"Del Vecchio","year":"2005","journal-title":"J Renal Nutr"},{"key":"10.1016\/j.jare.2016.02.004_b0175","series-title":"Clinical Diagnosis and Management by Laboratory Methods","first-page":"541","article-title":"Cytokines and adhesion molecules","author":"Massey","year":"2001"},{"key":"10.1016\/j.jare.2016.02.004_b0180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/0962935031000096935","article-title":"Acute effect of hemodialysis on serum levels of the proinflammatory cytokines","volume":"12","author":"Tarakc","year":"2003","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jare.2016.02.004_b0185","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/14.3.676","article-title":"Influence of dialysis with polyamide vs. haemophan haemodialysers on monokines and complement activation during a 4-month long-term study","volume":"14","author":"Girndt","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2016.02.004_b0190","unstructured":"Carrero JJ, Axelsson J, Snaedal-Jonsdottir S. Low haemoglobin in prevalent HD patients is associated with higher inflammatory status: impact of variations in the gene encoding for interleukin-6. In: Am soc nephrol congress; 2006 [SA-PO30]."},{"key":"10.1016\/j.jare.2016.02.004_b0195","first-page":"338","article-title":"C-reactive protein in the assessment of iron status in patients on hemodialysis","volume":"26","author":"Rathaus","year":"2009","journal-title":"G Ital Nefrol"},{"key":"10.1016\/j.jare.2016.02.004_b0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1159\/000121478","article-title":"Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients","volume":"28","author":"Costa","year":"2008","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.jare.2016.02.004_b0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"Van der Putten","year":"2008","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.jare.2016.02.004_b0210","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2016.02.004_b0215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.jare.2016.02.004_b0220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5414\/CNP60335","article-title":"Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients","volume":"60","author":"DeVita","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.03330807","article-title":"Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients","volume":"3","author":"Agarwal","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0230","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1523-1755.2004.00969.x","article-title":"Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin","volume":"66","author":"Terawaki","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.jare.2016.02.004_b0235","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1515\/CCLM.2009.303","article-title":"Serum albumin fragmentation in end-stage renal disease patients \u2013 a pilot study","volume":"47","author":"Donadio","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jare.2016.02.004_b0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2369-12-59","article-title":"The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients","volume":"12","author":"Roehrs","year":"2011","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.jare.2016.02.004_b0245","article-title":"Selenium supplementation to chronic kidney disease patients on hemodialysis has no effect on superoxide dismutase activity and malondialdehyde concentration in blood","volume":"1","author":"Zachara","year":"2014","journal-title":"Austin Therap"},{"key":"10.1016\/j.jare.2016.02.004_b0250","first-page":"S30","article-title":"Oxidation parameters in complete correction of renal anemia","volume":"53","author":"Ludat","year":"2000","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1016\/j.jare.2016.02.004_b0255","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/ndt\/gfl376","article-title":"A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation","volume":"21","author":"Sosa","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jare.2016.02.004_b0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/ajkd.2001.26094","article-title":"Comet assay analysis identifies genomic damage in lymphocytes of uremic patients","volume":"38","author":"Stopper","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jare.2016.02.004_b0265","article-title":"Effect of hemodialysis therapy on oxidative stress in patients with chronic renal failure","volume":"26","author":"Gonz\u00e1lez","year":"2006","journal-title":"Nefrolog\u00eda"},{"key":"10.1016\/j.jare.2016.02.004_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1253\/circj.72.1","article-title":"Redox regulation in the extracellular environment","volume":"72","author":"Ottaviano","year":"2008","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.jare.2016.02.004_b0275","first-page":"274","article-title":"Evaluation of lipid peroxidation and erythrocyte glutathione peroxidase and superoxide dismutase in hemodialysis patients","volume":"23","author":"Montazerifar","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.jare.2016.02.004_b0280","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10157-010-0310-3","article-title":"Effects of hemodialysis period on levels of blood trace elements and oxidative stress","volume":"14","author":"Koca","year":"2010","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jare.2016.02.004_b0285","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1440-1797.2005.00424.x","article-title":"Efficacy and safety of oral versus intravenous ascorbic acid for anemia in hemodialysis patients","volume":"10","author":"Chan","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jare.2016.02.004_b0290","first-page":"1874","article-title":"Effects of oral vitamin C supplementation on oxidative stress and inflammation status in hemodialysis patients","volume":"20","author":"Fumeron","year":"2005","journal-title":"NDT"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:41:47Z","timestamp":1761856907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123216000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2090123216000217"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2016.02.004","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease: Molecular and biochemical studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2016.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}